According to Biotest 's latest financial reports the company's current earnings are C$0.77 Billion. In 2023 the company made an earning of C$0.21 Billion, an increase over its 2022 earnings that were of -C$16.02 Million. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | C$0.12 B | -40.16% |
2023 | C$0.21 B | -1455.72% |
2022 | -C$16.02 Million | -79.44% |
2021 | -C$77.92 Million | 359.41% |
2020 | -C$16.96 Million | -213.86% |
2019 | C$14.89 M | -20.6% |
2018 | C$18.76 M | -135.69% |
2017 | -C$52.57 Million | -139.86% |
2016 | C$0.13 B | -227.25% |
2015 | -C$0.11 Billion | -199.09% |
2014 | C$0.10 B | 5.24% |
2013 | C$99.37 M | 29.54% |
2012 | C$76.71 M | -35.34% |
2011 | C$0.11 B | 28.46% |
2010 | C$92.35 M | -31.44% |
2009 | C$0.13 B |